Evaluation of Pulmonary Functions After Discharge in Pediatric Patients with COVID-19: A Prospective Study

Sevcan Ipek1, Sukru Gungor2, Ufuk Utku Gullu3

  • 1Department of Pediatrics, Kahramanmaraş Sütçü İmam University Medical Faculty, Kahramanmaraş, Türkiye.

Sisli Etfal Hastanesi Tip Bulteni
|October 28, 2022
PubMed

Insights

Pediatric patients recovering from COVID-19 showed abnormal pulmonary function tests (PFTs), indicating potential mixed-type lung disease. Further research is needed to understand long-term outcomes in these children.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • COVID-19 can affect multiple organ systems, including the lungs.
  • Long-term respiratory sequelae in pediatric COVID-19 survivors are not fully understood.
  • Assessing pulmonary function post-infection is crucial for evaluating recovery and potential complications.

Purpose of the Study:

  • To investigate pulmonary function in pediatric patients after recovery from COVID-19.
  • To compare spirometry results between recovered pediatric COVID-19 patients and a healthy control group.
  • To identify potential respiratory abnormalities and their characteristics in this population.

Main Methods:

  • A prospective study included pediatric patients (5-18 years) hospitalized with COVID-19 and discharged after recovery.
  • Pulmonary function tests (PFTs) were conducted using spirometry.
  • Results were compared between the patient group (n=34) and a control group (n=33).

Main Results:

  • Pediatric patients exhibited significantly lower forced vital capacity (FVC%) and forced expiratory volume in the first second (FEV1%) compared to controls.
  • FEV1/FVC% was also significantly reduced in the patient group.
  • Forced expiratory flow (FEF) 25-75% showed no significant difference, but a moderate negative correlation with hospital stay length was observed.

Conclusions:

  • Pulmonary function tests revealed abnormalities in pediatric patients after recovering from COVID-19.
  • The findings suggest a potential development of mixed-type lung disease.
  • Further long-term and short-term studies are essential to fully understand the prognosis for these patients.
Abstract

Related Concept Videos

Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
422
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
363
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
31
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
426
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
319